Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 May;15(3):283-284.
doi: 10.2450/2017.0035-17.

Italian consumption of plasma-derived factor VIII after the SIPPET study

Giuseppe Traversa  1 , Francesco Trotta  2
Affiliations
Comment

Italian consumption of plasma-derived factor VIII after the SIPPET study

Giuseppe Traversa et al. Blood Transfus. 2017 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest.

Comment on

References

    1. Peyvandi F, Mannucci PM, Garagiola I, et al. A randomized trial of factor VIII and neutralizing antibodies in hemophilia A. N Engl J Med. 2016;374:2054–64. - PubMed
    1. Arcieri R, Calizzani G, Candura F, Mannucci PM. The increased demand for plasma-derived factor VIII in Italy. Blood Transfus. 2017;15:279–80. - PMC - PubMed
    1. Traversa G, Trotta F. [Head to head comparisons to ascertain whether the new drug is innovative: the case of factor VIII containing products]. Ric & Pra. 2016;32:164–5. [In Italian.]
    1. Rocino A, Coppola A, Franchini M, et al. Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. Blood Transfus. 2014;12:575–98. - PMC - PubMed
    1. Franchini M, Coppola A, Rocino A, et al. Systematic review of the role of FVIII concentrates in inhibitor development in previously untreated patients with severe hemophilia a: a 2013 update. Semin Thromb Hemost. 2013;39:752–66. - PubMed